LPCN Stock Recent News Lipocine Inc (LPCN) 3.95 11/09/2014 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lipocine Inc (LPCN) 3.95 $LPCN

Nasdaq stocks posting largest percentage increases
AP - Thu Oct 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
TSCO: 74.56 (+0.16), SCSS: 26.14 (+0.12), XPLR: 5.88 (+0.14), LAKE: 13.29 (+0.42), LPCN: 3.95 (-0.21), LAWS: 22.97 (+0.05), VICR: 12.90 (-0.14), EGHT: 7.64 (+0.11), INFN: 13.99 (+0.21)

Lipocine Announces Positive Top-Line Results in Phase 2a Study of LPCN 1111
GlobeNewswire - Mon Oct 13, 6:09AM CDT
Candidate For Once Daily Dosing
LPCN: 3.95 (-0.21)

IPOs and Transactions Week in Review: September 29 - October 3
PR Newswire - Mon Oct 06, 1:25PM CDT
Vintage, the capital markets division of PR Newswire, has released its weekly IPO and Transaction summary.
RCAP: 11.32 (+0.35), CPTA: 18.68 (+0.26), PTN: 0.75 (-0.03), LPCN: 3.95 (-0.21), XGTI: 1.43 (+0.06), ENRJ: 4.48 (+0.19), SINO: 2.16 (+0.02)

SOXX, XONE, LPCN, Added To Naked Short Lists Today
M2 - Mon Oct 06, 9:30AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. iShares PHLX SOX Semiconductor Sector Index Fund (NASDAQ:SOXX), (NASDAQ:XONE), (NASDAQ:LPCN). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
XONE: 20.90 (-0.46), LPCN: 3.95 (-0.21), SOXX: 86.76 (-0.79)

Nasdaq stocks posting largest volume increases
AP - Thu Sep 25, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
OBCI: 3.48 (+0.03), LYTS: 7.08 (-0.17), ALCS: 0.30 (+0.01), ENVI: 1.72 (+0.02), JACQ: 11.00 (unch), LPCN: 3.95 (-0.21), FNJN: 3.00 (+0.01), RITT: 1.16 (-0.02), LAND: 10.92 (-0.37), ACOR: 35.11 (-0.85), FORD: 1.18 (unch)

Why Lipocine (LPCN) Stock Is Surging in Morning Trading Today
at The Street - Wed Sep 24, 8:50AM CDT
Shares of Lipocine (LPCN) soared in morning trading Wednesday after the pharmaceutical company announced positive results from its Phase 3 trial of its oral treatment LPCN 1021 for low testosterone.
LPCN: 3.95 (-0.21)

Lipocine Announces Positive Top-Line Results in Its Phase 3 Study of LPCN 1021 for Oral Testosterone Replacement Therapy
GlobeNewswire - Wed Sep 24, 7:30AM CDT
-- Met primary efficacy endpoint by successfully restoring testosterone levels to the normal range in 88% of the subjects
LPCN: 3.95 (-0.21)

Lipocine to Host Conference Call and Webcast to Discuss Top-Line Results From the Phase 3 Study of LPCN 1021
GlobeNewswire - Tue Sep 23, 3:00PM CDT
Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, today announced that the Company will host a conference call and webcast tomorrow, September 24, 2014 at 8:45 a.m. Eastern time to discuss top-line results from its Study of Oral Androgen Replacement ("SOAR" pivotal Phase 3 clinical study (http://clinicaltrials.gov/show/NCT02081300). The Company plans to issue a press release detailing top-line results tomorrow prior to the conference call.
LPCN: 3.95 (-0.21)

Lipocine Announces First Patient Dosed in Phase 1 Study in Pregnant Women of LPCN 1107, Potentially the First Oral Product for the Prevention of Preterm Birth
GlobeNewswire - Mon Sep 08, 3:16PM CDT
Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, today announced the first patient was dosed in a Phase 1 study in pregnant women of LPCN 1107, the company's oral hydroxyprogesterone caproate (HPC) product candidate. The primary objectives of the study will be to determine safety, tolerability and pharmacokinetics of oral administration of LPCN 1107 in pregnant subjects.
LPCN: 3.95 (-0.21)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nature-Based Solutions: The Economic And Community Impact

Updated Category News Views 6

Harnessing Nature to Boost Economies You ever stop to think about how nature itself might just be the best investment? Well, the Walton Family Foundation surely does, betting big on nature-based solutions. Their latest initiative, 'Human Nature,' is shedding light on how these solutions aren't just saving ecosystems — they're fortifying economies and enriching...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 2

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

Updated Category News Views 3

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Continue Reading
Annex Brands Grows with Bastrop's PostalAnnex Opening

Updated Category News Views 2

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Continue Reading
HNTB Expands in Capital Region: A Strategic Move

Updated Category News Views 2

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Continue Reading
Lititz Mutual Embraces AI with Guidewire ProNavigator

Updated Category News Views 5

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

Continue Reading
Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 3

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 1

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 3

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading
Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 5

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading

Top 5 Most Recently Viewed Articles

Deutsche Bank Upgrades General Motors to 'Buy' with Optimism

Updated Category News Views 197

Deutsche Bank Upgrades General Motors Company Deutsche Bank has recently raised its rating on General Motors Company (NYSE: GM) from 'Hold' to 'Buy'. This strategic decision is based on several factors, including significant shifts in the company’s operations in China, advancements in its Cruise division, and a proactive share buyback program. Analysts at Deutsche Bank...

Continue Reading
Smart Sand, Inc. Reports Second Quarter Results with Growth

Updated Category News Views 123

Smart Sand, Inc. Reports Strong Second Quarter Performance Smart Sand, Inc. (NASDAQ: SND), a leading provider of Northern White frac sand and industrial sand, recently shared its financial results for the latest quarter, showcasing a robust performance. In the second quarter of 2025, the Company achieved significant milestones with its revenue reaching $85.8 million. This...

Continue Reading
Community Health Engagement Through No-Cost Screenings Initiative

Updated Category News Views 72

Community Health Engagement Through No-Cost Screenings Initiative In an effort to enhance the well-being of communities, Care Access has teamed up with the City of District Heights to provide no-cost health screenings at the District Heights Senior Center. This initiative is part of a broader strategy to make vital health resources accessible to all residents. About the...

Continue Reading
Syndax Pharmaceuticals (NASDAQ: SNDX) Faces Market Challenges

Updated Category News Views 122

Syndax Pharmaceuticals (NASDAQ: SNDX) and Its Market Journey Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) has recently made headlines as its stock price has fallen to a 52-week low of $12.75. This decline is indicative of the current hurdles the biopharmaceutical company is facing in a challenging market landscape. Investors have noted that the stock is currently in an...

Continue Reading
Mohr Capital Expands Portfolio with New Industrial Acquisitions

Updated Category News Views 355

Mohr Capital Expands Portfolio with New Industrial Acquisitions Mohr Capital, a well-established real estate investment firm, has successfully acquired two industrial properties through an innovative 18-year sale leaseback transaction. This strategic move further enhances the company's already impressive portfolio and strengthens its presence in critical sectors. This...

Continue Reading